Postoperative Ketoacidosis With Hypoglycemia in a Nondiabetic Patient Taking Dapagliflozin for Heart Failure: A Case Report

Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are relatively new antidiabetic drugs, which have been recently approved for heart failure treatment. Although treatment interruption is recommended 3 to 4 days before surgery, it is unclear whether SGLT-2 inhibitors should be discontinued when pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Seki, Hiroyuki, Watanabe, Hidenobu, Yorozu, Tomoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323548/
https://www.ncbi.nlm.nih.gov/pubmed/35285818
http://dx.doi.org/10.1213/XAA.0000000000001570

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323548/
https://www.ncbi.nlm.nih.gov/pubmed/35285818
http://dx.doi.org/10.1213/XAA.0000000000001570

Ejemplares similares